Highly active antiretroviral therapy and coronary heart disease: the need for perspective

AIDS. 2001:15 Suppl 5:S193-201. doi: 10.1097/00002030-200100005-00023.

Authors

M Egger¹, C Junghans, N Friis-Møller, J D Lundgren

Affiliation

¹ MRC Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Bristol, UK. m.egger@bristol.ac.uk

PMID: 11816168
DOI: 10.1097/00002030-200100005-00023

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Adult
Aged
Aged, 80 and over
Anti-HIV Agents / adverse effects*
Antiretroviral Therapy, Highly Active / adverse effects*
Coronary Disease / epidemiology*
Coronary Disease / etiology*
HIV Infections / drug therapy*
Humans
Lipodystrophy / chemically induced
Lipodystrophy / complications
Male
Middle Aged
Risk Factors

Substances

Anti-HIV Agents